Apotex Paxil ANDA: Presence Of Hemihydrate Does Not Infringe GSK’s Patent
Executive Summary
Apotex' generic version of Paxil would not infringe GSK's hemihydrate paroxetine patent because the generic does not contain a commercially significant amount of hemihydrate crystals, a Chicago district court decision says
You may also be interested in...
Ivax Zyprexa Patent Challenge Could Benefit From Paxil Invalidity Ruling
Ivax believes its challenge to Lilly's Zyprexa patent will get a boost from a recent appellate court decision invalidating a GlaxoSmithKline patent claim for Paxil
Ivax Zyprexa Patent Challenge Could Benefit From Paxil Invalidity Ruling
Ivax believes its challenge to Lilly's Zyprexa patent will get a boost from a recent appellate court decision invalidating a GlaxoSmithKline patent claim for Paxil
PTO Tougher On Patent Claims Following Claritin Metabolite Ruling – Attorney
Patenting drug claims has become more difficult due to recent court rulings in Waxman/Hatch cases, attorney Anthony Insogna said during a panel discussion at the J.P. Morgan health care conference in San Francisco Jan. 14